Aldosterone inhibits the fetal program and increases hypertrophy in the heart of hypertensive mice

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Azibani, Feriel ^a   Devaux, Yvan ^b   Coutance, Guillaume ^a   Schlossarek, Saskia ^c   Polidano, Evelyne ^a   Fazal, Loubina ^a   Merval, Regine ^a   Carrier, Lucie ^c,d   Solal, Alain Cohen ^a,e   Chatziantoniou, Christos ^f   Launay, Jean Marie ^a,e   Samuel, Jane Lise ^a,e   Delcayre, Claude ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d CNRS   (France)

^e HÔPITAL LARIBOISIÈRE   (France)

^f INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; EPLERENONE; MESSENGER RNA; MICRORNA; MICRORNA 208B; MINERALOCORTICOID RECEPTOR; MYOSIN HEAVY CHAIN ALPHA; TRANSCRIPTION FACTOR SOX6; UNCLASSIFIED DRUG; BETA MYOSIN HEAVY CHAIN PROTEIN, MOUSE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MYOSIN HEAVY CHAIN; NATRIURETIC FACTOR; PHOSPHOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EMBRYO; GENE; GENE EXPRESSION; HEART VENTRICLE HYPERTROPHY; HYPERALDOSTERONISM; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; INTRON; MOUSE; MYH7 GENE; NONHUMAN; NPPA GENE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; WESTERN BLOTTING; ANIMAL; CARDIOMEGALY; DRUG EFFECT; FEMALE; FETUS; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

MUS; MUS MUSCULUS; RODENTIA;

ALDOSTERONE; ANIMALS; CARDIOMEGALY; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FEMALE; FETUS; GENE EXPRESSION REGULATION; HYPERALDOSTERONISM; HYPERTENSION; MALE; MICE; MICE, TRANSGENIC; MICRORNAS; MYOSIN HEAVY CHAINS; NATRIURETIC PEPTIDES; PHOSPHOPROTEINS; SIGNAL TRANSDUCTION;

EID: 84861614304     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038197     Document Type: Article

References (37)

1. Swynghedauw B, (1999) Molecular mechanisms of myocardial remodeling. Physiol Rev 79: 215-262.
2. Brilla CG, Weber KT, (1992) Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med 120: 893-901.
3. Robert V, Van Thiem N, Cheav SL, Mouas C, Swynghedauw B, et al. (1994) Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension. Hypertension 24: 30-36.
4. Zannad F, Alla F, Dousset B, Perez A, Pitt B, (2000) Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators. Circulation 102: 2700-2706.
5. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, et al. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341: 709-717.
6. Dartsch T, Fischer R, Gapelyuk A, Weiergraeber M, Ladage D, et al. (2011) Aldosterone induces electrical remodeling independent of hypertension. Int J Cardiol In press.
7. Matsumura K, Fujii K, Oniki H, Oka M, Iida M, (2006) Role of aldosterone in left ventricular hypertrophy in hypertension. Am J Hypertens 19: 13-18.
8. Okoshi MP, Yan X, Okoshi K, Nakayama M, Schuldt AJ, et al. (2004) Aldosterone directly stimulates cardiac myocyte hypertrophy. J Card Fail 10: 511-518.
9. Barry SP, Davidson SM, Townsend PA, (2008) Molecular regulation of cardiac hypertrophy. Int J Biochem Cell Biol 40: 2023-2039.
10. Akazawa H, Komuro I, (2003) Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res 92: 1079-1088.
11. van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, et al. (2009) A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 17: 662-673.
12. von Hofsten J, Elworthy S, Gilchrist MJ, Smith JC, Wardle FC, et al. (2008) Prdm1- and Sox6-mediated transcriptional repression specifies muscle fibre type in the zebrafish embryo. EMBO Rep 9: 683-689.
13. Caron KM, James LR, Kim HS, Morham SG, Sequeira Lopez ML, et al. (2002) A genetically clamped renin transgene for the induction of hypertension. Proc Natl Acad Sci U S A 99: 8248-8252.
14. Huby AC, Rastaldi MP, Caron K, Smithies O, Dussaule JC, et al. (2009) Restoration of podocyte structure and improvement of chronic renal disease in transgenic mice overexpressing renin. PLoS One 4: e6721.
15. Garnier A, Bendall JK, Fuchs S, Escoubet B, Rochais F, et al. (2004) Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice. Circulation 110: 1819-1825.
16. Ambroisine ML, Favre J, Oliviero P, Rodriguez C, Gao J, et al. (2007) Aldosterone-induced coronary dysfunction in transgenic mice involves the calcium-activated potassium (BKCa) channels of vascular smooth muscle cells. Circulation 116: 2435-2443.
17. Levy BI, Duriez M, Samuel JL, (2001) Coronary microvasculature alteration in hypertensive rats. Effect of treatment with a diuretic and an ACE inhibitor. Am J Hypertens 14: 7-13.
18. Messaoudi S, Milliez P, Samuel JL, Delcayre C, (2009) Cardiac aldosterone overexpression prevents harmful effects of diabetes in the mouse heart by preserving capillary density. FASEB J 23: 2176-2185.
19. Milliez P, Deangelis N, Rucker-Martin C, Leenhardt A, Vicaut E, et al. (2005) Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction. Eur Heart J 26: 2193-2199.
20. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
21. Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, et al. (2005) Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433: 647-653.
22. Harada E, Yoshimura M, Yasue H, Nakagawa O, Nakagawa M, et al. (2001) Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes. Circulation 104: 137-139.
23. Sugiyama T, Yoshimoto T, Tsuchiya K, Gochou N, Hirono Y, et al. (2005) Aldosterone induces angiotensin converting enzyme gene expression via a JAK2-dependent pathway in rat endothelial cells. Endocrinology 146: 3900-3906.
24. Lopez-Andres N, Martin-Fernandez B, Rossignol P, Zannad F, Lahera V, et al. (2011) A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone. Am J Physiol Heart Circ Physiol 301: H2372-2382.
25. Pitt B, Reichek N, Willenbrock R, Zannad F, Phillips RA, et al. (2003) Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation 108: 1831-1838.
26. Tanabe A, Naruse M, Naruse K, Hase M, Yoshimoto T, et al. (1997) Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension. Hypertens Res 20: 85-90.
27. Bauwens FR, Duprez DA, De Buyzere ML, De Backer TL, Kaufman JM, et al. (1991) Influence of the arterial blood pressure and nonhemodynamic factors on left ventricular hypertrophy in moderate essential hypertension. Am J Cardiol 68: 925-929.
28. Yoshida C, Goda A, Naito Y, Nakaboh A, Matsumoto M, et al. (2011) Role of plasma aldosterone concentration in regression of left-ventricular mass following antihypertensive medication. J Hypertens 29: 357-363.
29. Fraccarollo D, Berger S, Galuppo P, Kneitz S, Hein L, et al. (2011) Deletion of cardiomyocyte mineralocorticoid receptor ameliorates adverse remodeling after myocardial infarction. Circulation 123: 400-408.
30. Takeda Y, Yoneda T, Demura M, Usukura M, Mabuchi H, (2002) Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy. Circulation 105: 677-679.
31. Robert V, Heymes C, Silvestre JS, Sabri A, Swynghedauw B, et al. (1999) Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis. Hypertension 33: 981-986.
32. Komuro I, Yazaki Y, (1993) Control of cardiac gene expression by mechanical stress. Annu Rev Physiol 55: 55-75.
33. Sepulveda JL, Vlahopoulos S, Iyer D, Belaguli N, Schwartz RJ, (2002) Combinatorial expression of GATA4, Nkx2-5, and serum response factor directs early cardiac gene activity. J Biol Chem 277: 25775-25782.
34. El Jamali A, Freund C, Rechner C, Scheidereit C, Dietz R, et al. (2004) Reoxygenation after severe hypoxia induces cardiomyocyte hypertrophy in vitro: activation of CREB downstream of GSK3beta. FASEB J 18: 1096-1098.
35. Grossmann C, Wuttke M, Ruhs S, Seiferth A, Mildenberger S, et al. (2010) Mineralocorticoid receptor inhibits CREB signaling by calcineurin activation. FASEB J 24: 2010-2019.
36. Leopold JA, Dam A, Maron BA, Scribner AW, Liao R, et al. (2007) Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat Med 13: 189-197.
37. Kato T, Muraski J, Chen Y, Tsujita Y, Wall J, et al. (2005) Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt. J Clin Invest 115: 2716-2730.